Back to Pharma and BioTech Daily

Podcast Episode

Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 | Pharma and Biotech Daily

Pharma and BioTech Daily·Pharma and BioTech News·5 September 2026·5 min
Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 | Pharma and Biotech Daily cover art
HomeSearchProfile